Harrington v. Purdue Pharma L.P. | |
---|---|
Argued December 4, 2023 Decided June 27, 2024 | |
Full case name | William K. Harrington, United States Trustee, Region 2 v. Purdue Pharma L.P., et al. |
Docket no. | 23-124 |
Citations | 603 U.S. 204 (more) |
Argument | Oral argument |
Decision | Opinion |
Case history | |
Prior | Bankruptcy Court's Confirmation Order and related Advance Order vacated, In re Purdue Pharma, 635 B.R. 26 (S.D.N.Y., 2021), order affirmed in part, reversed in part, In re Purdue Pharma LP, 69 F. 4th 45 (2nd Cir., May 30, 2023); cert. granted (Aug. 10, 2023) |
Questions presented | |
Whether the Bankruptcy Code authorizes a court to approve, as part of a plan of reorganization under Chapter 11 of the Bankruptcy Code, a release that extinguishes claims held by nondebtors against nondebtor third parties, without the claimants’ consent. | |
Holding | |
The bankruptcy code does not authorize a release and injunction that, as part of a plan of reorganization under Chapter 11, effectively seek to discharge claims against a nondebtor without the consent of affected claimants. | |
Court membership | |
| |
Case opinions | |
Majority | Gorsuch, joined by Thomas, Alito, Barrett, Jackson |
Dissent | Kavanaugh, joined by Roberts, Sotomayor, Kagan |
Laws applied | |
Title 11 of the United States Code |
Harrington v. Purdue Pharma L.P., 603 U.S. 204 (2024), is a United States Supreme Court case regarding Chapter 11 of the Bankruptcy Code.[1] The case addressed the 2022-2023 Purdue Pharma bankruptcy settlement and whether, under Chapter 11 of the Bankruptcy Code, a release extinguishing claims held by nondebtors against nondebtor third parties, without the claimants’ consent could move forward. Following deliberations, the justices determined that the Bankruptcy Code did not authorize the claimant's order, blocking the bankruptcy plan.